STOCK TITAN

[10-Q/A] Minim, Inc. Amended Quarterly Earnings Report

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
10-Q/A
Rhea-AI Filing Summary

MYT Netherlands Parent B.V. (NYSE: MYTE) — Form 144 filing discloses additional insider share sales by CEO Michael Kliger.

  • Proposed sale: 274,174 common shares (≈0.20 % of the 136.4 m shares outstanding) through Morgan Stanley; estimated value $2.26 m; anticipated sale date 28 Jul 2025 on the NYSE.
  • Source of shares: 182,216 shares granted via Phantom Award (20 Jan 2021) and 91,958 RSUs vested 30 Jun 2025.
  • Prior 3-month activity: Kliger sold about 989,862 shares for total gross proceeds near $8 m under a Rule 10b5-1 program.

The filer certifies no undisclosed adverse information and relies on a pre-arranged trading plan. No operating or earnings data are provided.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Deposito del modulo 144 rivela ulteriori vendite di azioni da parte dell'insider, il CEO Michael Kliger.

  • Vendita proposta: 274.174 azioni ordinarie (circa lo 0,20% delle 136,4 milioni di azioni in circolazione) tramite Morgan Stanley; valore stimato di 2,26 milioni di dollari; data prevista per la vendita 28 luglio 2025 alla NYSE.
  • Origine delle azioni: 182.216 azioni concesse tramite Phantom Award (20 gennaio 2021) e 91.958 RSU maturate il 30 giugno 2025.
  • Attività negli ultimi 3 mesi: Kliger ha venduto circa 989.862 azioni per un ricavo lordo totale vicino agli 8 milioni di dollari nell'ambito di un programma Rule 10b5-1.

Il dichiarante certifica l'assenza di informazioni negative non divulgate e si basa su un piano di trading predefinito. Non sono forniti dati operativi o sugli utili.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Presentación del Formulario 144 revela ventas adicionales de acciones por parte del insider, el CEO Michael Kliger.

  • Venta propuesta: 274,174 acciones ordinarias (≈0.20 % de las 136.4 millones de acciones en circulación) a través de Morgan Stanley; valor estimado de 2.26 millones de dólares; fecha anticipada de venta 28 de julio de 2025 en la NYSE.
  • Fuente de las acciones: 182,216 acciones otorgadas mediante Phantom Award (20 de enero de 2021) y 91,958 RSU que vencen el 30 de junio de 2025.
  • Actividad previa de 3 meses: Kliger vendió aproximadamente 989,862 acciones por ingresos brutos cercanos a 8 millones de dólares bajo un programa Rule 10b5-1.

El declarante certifica que no hay información adversa no divulgada y se basa en un plan de trading preestablecido. No se proporcionan datos operativos ni de ganancias.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Form 144 제출은 CEO Michael Kliger의 추가 내부자 주식 매도를 공개합니다.

  • 예정 매도: Morgan Stanley를 통한 보통주 274,174주(총 발행 주식 1억 3,640만 주의 약 0.20%); 추정 가치 226만 달러; 예상 매도일 2025년 7월 28일 NYSE에서.
  • 주식 출처: 2021년 1월 20일 부여된 Phantom Award 182,216주 및 2025년 6월 30일 만기되는 91,958 RSU.
  • 최근 3개월 활동: Kliger는 Rule 10b5-1 프로그램에 따라 약 989,862주를 매도하여 총 약 800만 달러의 매출을 올렸습니다.

신고자는 공개되지 않은 부정적 정보가 없음을 인증하며 사전 계획된 거래 계획에 의존합니다. 운영 또는 수익 데이터는 제공되지 않습니다.

MYT Netherlands Parent B.V. (NYSE : MYTE) — Dépôt du formulaire 144 révèle des ventes supplémentaires d’actions par l’initié, le PDG Michael Kliger.

  • Vente proposée : 274 174 actions ordinaires (≈0,20 % des 136,4 millions d’actions en circulation) via Morgan Stanley ; valeur estimée à 2,26 millions de dollars ; date prévue de la vente le 28 juillet 2025 à la NYSE.
  • Source des actions : 182 216 actions attribuées via Phantom Award (20 janvier 2021) et 91 958 RSU arrivant à échéance le 30 juin 2025.
  • Activité des 3 derniers mois : Kliger a vendu environ 989 862 actions pour un produit brut total proche de 8 millions de dollars dans le cadre d’un programme Rule 10b5-1.

Le déclarant certifie qu’aucune information défavorable non divulguée n’existe et s’appuie sur un plan de trading préétabli. Aucune donnée opérationnelle ou de résultats n’est fournie.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Form 144 Einreichung offenbart zusätzliche Insider-Aktienverkäufe durch CEO Michael Kliger.

  • Vorgeschlagener Verkauf: 274.174 Stammaktien (≈0,20 % von 136,4 Mio. ausstehenden Aktien) über Morgan Stanley; geschätzter Wert 2,26 Mio. USD; geplanter Verkaufstermin 28. Juli 2025 an der NYSE.
  • Herkunft der Aktien: 182.216 Aktien gewährt durch Phantom Award (20. Jan 2021) und 91.958 RSUs, die am 30. Juni 2025 fällig werden.
  • Aktivität der letzten 3 Monate: Kliger verkaufte etwa 989.862 Aktien mit einem Bruttoerlös von ca. 8 Mio. USD im Rahmen eines Rule 10b5-1 Programms.

Der Melder bestätigt, dass keine nicht offengelegten negativen Informationen vorliegen und stützt sich auf einen vorab vereinbarten Handelsplan. Es werden keine Betriebs- oder Gewinnzahlen bereitgestellt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR — CEO plans to sell 274 k more shares; cumulative insider selling nears 1 m, modest float impact but could weigh on sentiment.

While 274 k shares represent only 0.2 % of shares outstanding, the pattern of almost 1 m shares sold in the last quarter signals sustained insider distribution. Such activity often raises questions about management’s confidence in near-term upside and can create incremental supply that pressures the stock, especially for a company with limited trading liquidity. Because the sale is executed under a disclosed 10b5-1 plan, it does not necessarily imply negative non-public information, yet the magnitude and cadence of sales are worth monitoring. From a valuation standpoint, no fundamentals change — the filing is informational rather than operational. Overall impact is neutral to mildly negative due to perception risk rather than financial dilution.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Deposito del modulo 144 rivela ulteriori vendite di azioni da parte dell'insider, il CEO Michael Kliger.

  • Vendita proposta: 274.174 azioni ordinarie (circa lo 0,20% delle 136,4 milioni di azioni in circolazione) tramite Morgan Stanley; valore stimato di 2,26 milioni di dollari; data prevista per la vendita 28 luglio 2025 alla NYSE.
  • Origine delle azioni: 182.216 azioni concesse tramite Phantom Award (20 gennaio 2021) e 91.958 RSU maturate il 30 giugno 2025.
  • Attività negli ultimi 3 mesi: Kliger ha venduto circa 989.862 azioni per un ricavo lordo totale vicino agli 8 milioni di dollari nell'ambito di un programma Rule 10b5-1.

Il dichiarante certifica l'assenza di informazioni negative non divulgate e si basa su un piano di trading predefinito. Non sono forniti dati operativi o sugli utili.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Presentación del Formulario 144 revela ventas adicionales de acciones por parte del insider, el CEO Michael Kliger.

  • Venta propuesta: 274,174 acciones ordinarias (≈0.20 % de las 136.4 millones de acciones en circulación) a través de Morgan Stanley; valor estimado de 2.26 millones de dólares; fecha anticipada de venta 28 de julio de 2025 en la NYSE.
  • Fuente de las acciones: 182,216 acciones otorgadas mediante Phantom Award (20 de enero de 2021) y 91,958 RSU que vencen el 30 de junio de 2025.
  • Actividad previa de 3 meses: Kliger vendió aproximadamente 989,862 acciones por ingresos brutos cercanos a 8 millones de dólares bajo un programa Rule 10b5-1.

El declarante certifica que no hay información adversa no divulgada y se basa en un plan de trading preestablecido. No se proporcionan datos operativos ni de ganancias.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Form 144 제출은 CEO Michael Kliger의 추가 내부자 주식 매도를 공개합니다.

  • 예정 매도: Morgan Stanley를 통한 보통주 274,174주(총 발행 주식 1억 3,640만 주의 약 0.20%); 추정 가치 226만 달러; 예상 매도일 2025년 7월 28일 NYSE에서.
  • 주식 출처: 2021년 1월 20일 부여된 Phantom Award 182,216주 및 2025년 6월 30일 만기되는 91,958 RSU.
  • 최근 3개월 활동: Kliger는 Rule 10b5-1 프로그램에 따라 약 989,862주를 매도하여 총 약 800만 달러의 매출을 올렸습니다.

신고자는 공개되지 않은 부정적 정보가 없음을 인증하며 사전 계획된 거래 계획에 의존합니다. 운영 또는 수익 데이터는 제공되지 않습니다.

MYT Netherlands Parent B.V. (NYSE : MYTE) — Dépôt du formulaire 144 révèle des ventes supplémentaires d’actions par l’initié, le PDG Michael Kliger.

  • Vente proposée : 274 174 actions ordinaires (≈0,20 % des 136,4 millions d’actions en circulation) via Morgan Stanley ; valeur estimée à 2,26 millions de dollars ; date prévue de la vente le 28 juillet 2025 à la NYSE.
  • Source des actions : 182 216 actions attribuées via Phantom Award (20 janvier 2021) et 91 958 RSU arrivant à échéance le 30 juin 2025.
  • Activité des 3 derniers mois : Kliger a vendu environ 989 862 actions pour un produit brut total proche de 8 millions de dollars dans le cadre d’un programme Rule 10b5-1.

Le déclarant certifie qu’aucune information défavorable non divulguée n’existe et s’appuie sur un plan de trading préétabli. Aucune donnée opérationnelle ou de résultats n’est fournie.

MYT Netherlands Parent B.V. (NYSE: MYTE) — Form 144 Einreichung offenbart zusätzliche Insider-Aktienverkäufe durch CEO Michael Kliger.

  • Vorgeschlagener Verkauf: 274.174 Stammaktien (≈0,20 % von 136,4 Mio. ausstehenden Aktien) über Morgan Stanley; geschätzter Wert 2,26 Mio. USD; geplanter Verkaufstermin 28. Juli 2025 an der NYSE.
  • Herkunft der Aktien: 182.216 Aktien gewährt durch Phantom Award (20. Jan 2021) und 91.958 RSUs, die am 30. Juni 2025 fällig werden.
  • Aktivität der letzten 3 Monate: Kliger verkaufte etwa 989.862 Aktien mit einem Bruttoerlös von ca. 8 Mio. USD im Rahmen eines Rule 10b5-1 Programms.

Der Melder bestätigt, dass keine nicht offengelegten negativen Informationen vorliegen und stützt sich auf einen vorab vereinbarten Handelsplan. Es werden keine Betriebs- oder Gewinnzahlen bereitgestellt.

true --12-31 2024 Q3 0001467761 0001467761 2024-01-01 2024-09-30 0001467761 2025-07-25 0001467761 2024-09-30 0001467761 2023-12-31 0001467761 2024-07-01 2024-09-30 0001467761 2023-07-01 2023-09-30 0001467761 2023-01-01 2023-09-30 0001467761 us-gaap:PreferredStockMember 2023-12-31 0001467761 us-gaap:CommonStockMember 2023-12-31 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001467761 us-gaap:RetainedEarningsMember 2023-12-31 0001467761 us-gaap:PreferredStockMember 2024-03-31 0001467761 us-gaap:CommonStockMember 2024-03-31 0001467761 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001467761 us-gaap:RetainedEarningsMember 2024-03-31 0001467761 2024-03-31 0001467761 us-gaap:PreferredStockMember 2024-06-30 0001467761 us-gaap:CommonStockMember 2024-06-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001467761 us-gaap:RetainedEarningsMember 2024-06-30 0001467761 2024-06-30 0001467761 us-gaap:CommonStockMember 2022-12-31 0001467761 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001467761 us-gaap:RetainedEarningsMember 2022-12-31 0001467761 2022-12-31 0001467761 us-gaap:CommonStockMember 2023-03-31 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001467761 us-gaap:RetainedEarningsMember 2023-03-31 0001467761 2023-03-31 0001467761 us-gaap:CommonStockMember 2023-06-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001467761 us-gaap:RetainedEarningsMember 2023-06-30 0001467761 2023-06-30 0001467761 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001467761 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001467761 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001467761 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001467761 2024-01-01 2024-03-31 0001467761 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001467761 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001467761 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001467761 2024-04-01 2024-06-30 0001467761 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001467761 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001467761 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001467761 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001467761 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001467761 2023-01-01 2023-03-31 0001467761 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001467761 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001467761 2023-04-01 2023-06-30 0001467761 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001467761 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001467761 us-gaap:PreferredStockMember 2024-09-30 0001467761 us-gaap:CommonStockMember 2024-09-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001467761 us-gaap:RetainedEarningsMember 2024-09-30 0001467761 us-gaap:CommonStockMember 2023-09-30 0001467761 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001467761 us-gaap:RetainedEarningsMember 2023-09-30 0001467761 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number 1-37649

 

FIEE, INC. (formerly MINIM, INC.)

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   04-2621506
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
848 Elm Street, Manchester, NH   03101
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (833) 966-4646

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.01 per share   FIEE   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller Reporting Company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes ☐   No ☒

 

The number of shares outstanding of the registrant’s Common Stock, $0.01 par value, as of July 25, 2025, was 6,224,389 shares.

 

 

 

 

 

 

EXPLANATORY NOTE

 

FiEE, Inc., formerly known as Minim, Inc., (“Minim”, the “Company”, “we”, “our” and similar terms) is filing this Amendment No. 1 to the Company’s Quarterly Report on Form 10-Q (the “Form 10-Q/A”) for the period ended September 30, 2024 to amend and restate certain items presented in our Quarterly Report on Form 10-Q for the period ended September 30, 2024 which was initially filed with the U.S. Securities and Exchange Commission (“SEC”) on November 19, 2024 (the “Original Form 10-Q”). This amendment is limited in scope to make the following changes to the original filing:

 

To amend Part I – Item 1. Financial Statements.

 

To amend Part II - Item 6. Exhibits to include currently dated (certifications from the Company’s Principal Executive Officer and Principal Financial Officer as required by Sections 302 and 906 of the Sarbanes Oxley Act of 2002, which certifications are filed herewith as Exhibits 31.1, 31.2, 32.1 and 32.2.

 

The Form 10-Q/A contains our unaudited restated quarterly financial statements as of and for the three and nine months ended September 30, 2024. This Form 10-Q/A includes a restatement of our consolidated balance sheet as of September 30, 2024 and the related consolidated statements of operations, and stockholders’ equity for the three and nine months then ended. There are changes to the financial statements for the year ended December 31, 2023. This Form 10-Q/A also includes amendments to: the Chief Executive Officer and Chief Financial Officer certifications in Exhibits 31.1, 31.2, 32.1 and 32.2 and the financial statements formatted in Extensible Business Reporting Language (XBRL) in Exhibit 101.

 

This amendment has not been updated or amended to give effect to any subsequent events beyond those that existed as of the original filing date and should thus be read in conjunction with the original filing and any of the Company’s other filings with the SEC subsequent to the original filing, together with any amendments to those filings. Other than the filing of the information identified above, this amendment does not modify or update the disclosure in the original filing in any way.

 

Overview

 

The Audit Committee of the Company, after consultation with the Company’s management, concluded that the following financial statements for the period ended September 30, 2024 as previously filed by the Company with the SEC should no longer be relied upon due to errors in such financial statements relating to the recording and reporting of common stock shares outstanding, including earning per share.

 

Accordingly, investors should no longer rely upon the Company’s previously released financial statements for the period ended September 30, 2024 and should rely instead on the unaudited restated quarterly financial statements included in this Form 10-Q/A. The Company’s management identified an error in the shares of the Company’s common stock outstanding in the preparation of the Company’s financial statements for the fiscal year ended December 31, 2024.

 

For the fiscal year ended December 31, 2023, the outstanding shares of the Company’s common stock was incorrectly reported as 2,632,809. The corrected outstanding shares of the Company’s common stock is reported in this Form 10-Q/A as 2,789,020. For the period ended September 30, 2024, the outstanding shares of the Company’s common stock was incorrectly reported as 3,557,581. The corrected outstanding shares of the Company’s common stock is reported in this Form 10-Q/A as 3,713,792.

 

The error in the outstanding shares of the Company’s common stock did not impact the period ended September 30, 2023.

 

As a result of the restatement included herein, the Company is reporting 2,789,020 shares of the Company’s common stock outstanding for the year ended December 31, 2023, which is more than the 2,632,809 outstanding shares of the Company’s common stock reported in the Original Form 10-Q.

 

Consequently, the Company is reporting herein 3,713,792 shares of the Company’s common stock outstanding for the period ended September 30, 2024, which is more than the 3,557,581 shares of the Company’s common stock reported as outstanding in the Original Form 10-Q. Consequently, the Company is reporting herein weighted average common shares for the three months ended September 30, 2024 of 3,022,805 and basic and diluted net loss per share of $0.21 per share, compared to the weighted average common shares reported in the Original Form 10-Q of 2,866,594 and basic and diluted net loss of $0.22 per share. Consequently, the Company is reporting herein weighted average shares of the Company’s common stock for the nine months ended September 30, 2024 of 2,972,118 and basic and diluted net loss per share of $1.47 per share, compared to the weighted average shares of the Company’s common stock reported in the Original Form 10-Q of 2,815,907 and basic and diluted net loss of $1.55 per share.

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

FIEE, INC. (FORMERLY MINIM, INC.)

AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

 

                 
   

September 30,
2024
(Unaudited)
(Amended)

   

December 31,
2023

 
ASSETS                
Current assets                
Cash and cash equivalents   $ 191,724     $ 709,322  
Accounts receivable, net of allowance of doubtful accounts of $0 and $312,983 as of September 30, 2024 and December 31, 2023, respectively     -       701,377  
Inventories, net     -       9,952,647  
Prepaid expenses and other current assets     24,107       35,768  
Total current assets     215,831       11,399,114  
                 
Equipment, net     189,054       432,505  
Operating lease right-of-use assets, net     -       22,512  
Intangible assets, net     -       33,247  
Other assets     28,311       472,587  
Total assets   $ 433,196     $ 12,359,965  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                
Current liabilities                
Accounts payable   $ 307,781     $ 11,143,693  
Current maturities of operating lease liabilities     -       22,512  
Accrued expenses     684,269       1,077,843  
Total current liabilities     992,050       12,244,048  
                 
Total liabilities     992,050       12,244,048  
                 
Commitments and Contingencies (Note 7)                
                 
Stockholders’ equity (deficit)                
Preferred Stock, authorized: 10,000,000 shares at $0.001 par value; 2,000,000 shares issued and outstanding     1,358,573       -  
Common Stock, authorized: 60,000,000 shares at $0.01 par value; issued and outstanding: 3,713,792 shares at September 30, 2024 and 2,789,020 shares at December 31, 2023 respectively     490,145       480,897  
Additional paid-in capital     94,433,140       92,103,798  
Accumulated deficit     (96,840,712 )     (92,468,778 )
Total stockholders’ equity (deficit)     (558,854 )     115,917  
Total liabilities and stockholders’ equity (deficit)   $ 433,196     $ 12,359,965  

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

1

 

 

FIEE, INC. (FORMERLY MINIM, INC.)

AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)

 

                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2024
(Amended)
    2023     2024
(Amended)
    2023  
Net sales   $ -     $ 6,696,187     $ 639,893     $ 24,642,728  
Cost of goods sold     -       9,694,096       432,634       24,545,534  
Gross profit     -       (2,997,909 )     207,259       97,194  
                                 
Operating expenses:                                
Selling and marketing     -       2,073,636       66,171       9,386,157  
General and administrative     625,067       963,108       2,210,097       3,460,092  
Research and development     -     687,076       113,294       3,358,276  
Vendor liability forgiveness, net of asset transfers     -       -       2,200,929       -  
Total operating expenses     625,067       3,723,820       4,590,491       16,204,525  
                                 
Operating loss     (625,067 )     (6,721,729 )     (4,383,232 )     (16,107,331 )
                                 
Other income (expense):                                
Interest income (expense), net     -       (99,084 )     82       (356,644 )
Total other income (expense)     -       (99,084 )     82       (356,644 )
                                 
Loss before income taxes     (625,067 )     (6,820,813 )     (4,383,150 )     (16,463,974 )
                                 
Income tax expense (benefit)     -       (525 )     (11,216 )     24,451  
                                 
Net loss   $ (625,067 )   $ (6,820,287 )   $ (4,371,934 )   $ (16,488,425 )
                                 
Net loss per share:                                
Basic and diluted   $ (0.21 )   $ (3.61 )   $ (1.47 )   $ (8.74 )
                                 
Basic and diluted weighted average common and common equivalent shares     3,022,805       1,890,933       2,972,118       1,886,465  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

2

 

 

FIEE, INC. (FORMERLY MINIM, INC.)

AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity (deficit)

(Unaudited)

 

For the Nine months ended September 30, 2024 (Amended)

 

                                                         
    Preferred Stock     Common Stock     Additional
Paid In
    Accumulated        
    Shares     Amount     Shares     Amount     Capital     Deficit     Total  
Balance at December 31, 2023     -     $ -       2,789,020     $ 480,897     $ 92,103,798     $ (92,468,778 )   $ 115,917  
                                                         
Net loss     -       -       -       -       -       (3,258,955 )     (3,258,955 )
Preferred stock issuance     2,000,000       1,358,573       -       -       -       -       1,358,573  
Issuance of warrants     -       -       -       -       1,441,427       -       1,441,427  
Stock-based compensation     -       -       176,880       1,769       424,512       -       426,281  
Balance at March 31, 2024     2,000,000     $ 1,358,573       2,965,900     $ 482,666     $ 93,969,737     $ (95,727,733 )   $ 83,243  
                                                         
Net loss     -       -       -       -       -       (487,912 )     (487,912 )
Balance at June 30, 2024     2,000,000     $ 1,358,573       2,965,900     $ 482,666     $ 93,969,737     $ (96,215,645 )   $ (404,669 )
                                                         
Net loss     -       -       -       -       -       (625,067 )     (625,067 )
Stock-based compensation     -       -       747,892       7,479       463,403       -       470,882  
Balance at September 30, 2024     2,000,000     $ 1,358,573       3,713,792     $ 490,145     $ 94,433,140     $ (96,840,712 )   $ (558,854 )

 

For the Nine months ended September 30, 2023

 

                                         
    Common Stock     Additional
Paid In
    Accumulated        
    Shares     Amount     Capital     Deficit     Total  
Balance at December 31, 2022     1,877,970     $ 469,492     $ 90,710,030     $ (74,834,854 )   $ 16,344,668  
                                         
Net loss     -       -       -       (4,070,457 )     (4,070,457 )
Common stock issued for vested restricted units     9,565       2,391       (2,391 )     -       -  
Stock-based compensation     -       -       123,500       -       123,501  
Balance at March 31, 2023     1,887,535     $ 471,883     $ 90,831,139     $ (78,905,311 )   $ 12,397,711  
                                         
Net loss     -       -       -       (5,597,681 )     (5,597,681 )
Common stock issued for vested restricted stock units     739       7       (7 )     -       -  
Stock-based compensation     -       -       101,589       -       101,589  
Balance at June 30, 2023     1,888,274     $ 471,890     $ 90,932,721     $ (84,502,992 )   $ 6,901,619  
                                         
Net loss     -       -       -       (6,820,287 )     (6,820,287 )
Common stock issued for vested restricted stock units     10,191       102       (102 )     -       -  
Stock-based compensation     -       -       54,305       -       54,305  
Balance at September 30, 2023     1,898,466     $ 471,992     $ 90,986,924     $ (91,323,279 )   $ 135,637  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

3

 

 

FIEE, INC. (FORMERLY MINIM, INC.)

AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(Amended)

 

(11) EARNINGS (LOSS) PER SHARE (AMENDED)

 

Net loss per share for the three and nine months ended September 30, 2024 and 2023, respectively, are as follows:

 

Schedule of net income (loss) per share                                
    Three Months Ended     Nine Months Ended  
    September 30,
2024
(Amended)
    September 30,
2023
    September 30,
2024
(Amended)
    September 30,
2023
 
Numerator:                                
Net loss   $ (625,067 )   $ (6,820,287 )   $ (4,371,934 )   $ (16,488,425 )
                                 
Denominator:                                
Weighted average common shares - basic     3,022,805       1,890,933       2,972,118       1,886,465  
Effect of dilutive common share equivalents     -       -       -       -  
Weighted average common shares - dilutive     3,022,805       1,890,933       2,972,118       1,886,465  
                                 
Basic and diluted   $ (0.21 )   $ (3.61 )   $ (1.47 )   $ (8.74 )

 

Diluted loss per common share for the three and nine months ended September 30, 2024 and 2023 excludes the effects of 5,230,769 and 2,080 common share equivalents, respectively, since such inclusion would be anti-dilutive. The common share equivalents consist of shares of common stock issuable upon exercise of outstanding preferred stock, warrants, restricted stock units, and stock options.

 

4

 

 

ITEM 6. EXHIBITS

 

Exhibit No.   Exhibit Description
31.1   CEO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   CFO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   CEO Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.†
32.2   CFO Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.†
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Label Linkbase Document
101.PRE   XBRL Taxonomy Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 
* In accordance with Rule 12b-32 under the Securities Exchange Act of 1934, as amended, reference is made to the documents previously filed with the Securities and Exchange Commission, which documents are hereby incorporated by reference.
** Compensation Plan or Arrangement.
In accordance with Item 601(b)(32)(ii) of Regulation S-K, the certifications furnished in Exhibit 32.1 and Exhibit 32.2 hereto are deemed to accompany this Form 10-Q/A and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

 

5

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

FIEE, INC.

(Registrant)

     
Date: July 28, 2025 By: /s/ Li Wai Chung
   

Li Wai Chung

    Principal Executive Officer

 

6

Minim Inc

NASDAQ:MINM

MINM Rankings

MINM Latest News

MINM Latest SEC Filings

MINM Stock Data

24.11M
618.89k
88.68%
4.04%
Communication Equipment
Telephone & Telegraph Apparatus
Link
United States
TSUEN WAN